Information1 | |
---|---|
Image | ![]() |
BRC No. | RBRC02339 |
Type | Transgene Congenic![]() |
Species | Mus musculus |
Strain name | B6.Cg-Tg(Tec-p210 BCR/ABL1)1Homy |
Former Common name | p210<bcr/abl> Tg |
H-2 Haplotype | |
ES Cell line | |
Background strain | C57BL/6NCrlCrlj |
Appearance | black [a/a B/B C/C] |
Strain development | Developed by Drs. Honda and Hirai, University of Tokyo in 1998. |
Strain description | This transgenic strain expresses the p210 BCR/ABL1 gene. Tg mice show marked granulocyte hyperplasia and develop myeloproliferative disorders closely resembling human chronic myelogenous leukemia. |
Colony maintenance | Backcross to C57BL/6 (Hemizygote x C57BL/6NCrlCrlj) |
References | Blood, 91, 2067-2075 (1998). 9490692 Oncogene. 2008 May 29;27(24):3465-74. 18193087 Cancer Sci. 2009 Jul;100(7):1219-26. 19432895 Blood. 2009 May 7;113(19):4702-10. 19234145 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter BCR/ABL1p210 bcr/abl1 (human)UNBCR/ABL1mouse Tec Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter poly ASV40 polyA siganlUNpoly A |
Information2 | |
---|---|
Donor DNA | mouse Tec genomic DNA, human p210<bcr/abl> cDNA, SV40 virus poly A signal DNA |
Research application | Cancer Research Immunology and Inflammation Research |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. |
Depositor | Hiroaki Honda (Tokyo Women's Medical University) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Genotyping protocol -PCR- Necessary documents for ordering:
|
BRC mice in Publications |
---|
Sánchez-Sánchez B, Gutiérrez-Herrero S, López-Ruano G, Prieto-Bermejo R, Romo-González M, Llanillo M, Pandiella A, Guerrero C, Miguel JF, Sánchez-Guijo F, Del Cañizo C, Hernández-Hernández A. NADPH oxidases as therapeutic targets in chronic myelogenous leukemia. Clin Cancer Res 20(15) 4014-25(2014) 24833663 |